dc.creatorBillis A.
dc.date2007
dc.date2015-06-30T18:52:26Z
dc.date2015-11-26T14:39:06Z
dc.date2015-06-30T18:52:26Z
dc.date2015-11-26T14:39:06Z
dc.date.accessioned2018-03-28T21:44:34Z
dc.date.available2018-03-28T21:44:34Z
dc.identifier
dc.identifierInternational Braz J Urol. , v. 33, n. 4, p. 580 - 581, 2007.
dc.identifier16775538
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-34848909052&partnerID=40&md5=353e794fea35aacdc41b7a01609d6e2b
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/105185
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/105185
dc.identifier2-s2.0-34848909052
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1249859
dc.description[No abstract available]
dc.description33
dc.description4
dc.description580
dc.description581
dc.descriptionEpstein, J.I., Amin, M., Boccon-Gibod, L., Egevad, L., Humphrey, P.A., Mikuz, G., Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens (2005) Scand J Urol Nephrol Suppl, 216, pp. 34-63
dc.descriptionHan, M., Partin, A.W., Pound, C.R., Epstein, J.I., Walsh, P.C., Long-term biochemical disease-free and cancer-specific survival following anatomic radicl retropubic prostatectomy. The 15-year Johns Hopkins experience (2001) Urol Clin North Am, 28, pp. 555-565
dc.descriptionChan, T.Y., Partin, A.W., Walsh, P.C., Epstein, J.I., Prognostic significance of Gleason score 4+3 tumor at radical prostatectomy (2000) Urology, 56, pp. 823-827
dc.descriptionEichelberger, L.E., Cheng, L., Does pT2b cancer exist? Critical appraisal of the 2002 TNM classification of prostate cancer (2004) Cancer, 100, pp. 2573-2576
dc.descriptionQuintal, M.M., Magna, L.A., Guimaraes, M.S., Ruano, T., Ferreira, U., Billis, A., Prostate cancer pathologic pT2b (2002 TNM staging system): Does it exist? (2006) Int Braz J Urol, 32, pp. 43-47
dc.languageen
dc.publisher
dc.relationInternational Braz J Urol
dc.rightsaberto
dc.sourceScopus
dc.titleUpdated Nomogram To Predict Pathologic Stage Of Prostate Cancer Given Prostate-specific Antigen Level, Clinical Stage, And Biopsy Gleason Score (partin Tables) Based On Cases From 2000 To 2005
dc.typeNota


Este ítem pertenece a la siguiente institución